AAM
GILD icon

Arabesque Asset Management’s Gilead Sciences GILD Stock Holding History

Arabesque Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-41,171
Closed -$3.53M – 60
2022
Q4 		$3.53M Buy
41,171
+4,390
+12% +$348K 1.2% 24
2022
Q3 		$2.27M Buy
+36,781
New +$2.32M 1.11% 29
2020
Q4 		– Sell
-19,246
Closed -$1.22M – 87
2020
Q3 		$1.22M Buy
19,246
+49
+0.3% +$3.4K 1.09% 39
2020
Q2 		$1.48M Buy
19,197
+22
+0.1% +$1.69K 1% 47
2020
Q1 		$1.43M Buy
+19,175
New +$1.32M 2.97% 18

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arabesque Asset Management's GILD Position: Q1 2023 in Review

Arabesque Asset Management sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 41,171 shares — an estimated $3.53M sold.

Arabesque Asset Management first reported a position in GILD in Q1 2020 and held it in 5 quarters. The position peaked at $3.53M in Q4 2022. 1,737 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Arabesque Asset Management reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 41,171 Gilead Sciences shares in Q1 2023, an estimated $3.53M.
  • Arabesque Asset Management first reported a position in Gilead Sciences in Q1 2020 and held it in 5 quarters.
  • Arabesque Asset Management's Gilead Sciences position peaked at $3.53M in Q4 2022.
  • 1,737 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.